Vinyl chloride - A classical industrial toxicant of new interest

Critical Reviews in Toxicology

Volumn 35, Issue 4, 2005, Pages 307-323

  Bolt, Hermann M ^a  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

Carcinogenicity; Chloroethylene; Chloroethylene Oxide; DNA Etheno Adducts; Endogenous Genotoxins; Genotoxicity; Genotoxins; Mechanisms; Metabolism; Modes of Action; Vinyl Chloride

Indexed keywords

1,N 6 ETHENOADENINE; 3,N 4 ETHENOCYTOSINE; BIOLOGICAL MARKER; CHLOROACETALDEHYDE; CHLOROETHYLENE OXIDE; CONNEXIN 37; CYTOCHROME P450 2E1; DNA GLYCOSYLTRANSFERASE; ETHYLENE OXIDE DERIVATIVE; GENE PRODUCT; INDUSTRIAL TOXIC SUBSTANCE; N 2 ,3 ETHENOGUANINE; NUCLEOTIDE; PROTEIN P53; UNCLASSIFIED DRUG; VINYL CHLORIDE;

ANGIOSARCOMA; BIOASSAY; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CARCINOGENICITY; CLINICAL TRIAL; DNA ADDUCT; DNA BINDING; DNA REPAIR; DOSE RESPONSE; ENDOTHELIUM CELL; FATTY LIVER; GENE MUTATION; GENOTOXICITY; HEMOCHROMATOSIS; HEPATITIS; HUMAN; LIPID PEROXIDATION; LIVER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER PARENCHYMA; LIVER SARCOMA; META ANALYSIS; METABOLIC ACTIVATION; METABOLISM; MUTAGENICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; ONCOGENE H RAS; ONCOGENE K RAS; OXIDATION; OXIDATIVE STRESS; PROTO ONCOGENE; REVIEW; RISK ASSESSMENT; TOXICOKINETICS; TUMOR SUPPRESSOR GENE; WILSON DISEASE;

ANIMALS; CARCINOGENS; DNA; DNA REPAIR; HUMANS; INHALATION EXPOSURE; MUTAGENS; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; VINYL CHLORIDE;

ANIMALIA;

EID: 18844442090     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408440490915975     Document Type: Review

References (151)

1. Abu, M., and Waters, T. R. (2003). The main role of human thymine-DNA glycosylase is removal of thymine produced by deamination of 5-methylcytosine and not removal of ethenocytosine. J. Biol. Chem. 278(10):8739-8744.
2. Albertini, A., Clewell, H., Himmelstein, M.W., Morinello, E., Olin, S., Preston, J., Scarano, S., Smith, M.T., Swenberg, J., Tice, R., and Travis, C. (2003). The use of non-tumor data in risk assessment: Reflections on butadiene, vinyl chloride, and benzene. Regul. Toxicol. Pharmacol. 37:105-132.
3. 2-ethenoguanine in Chinese hamster ovary cell chromosomal DNA. Chem. Res. Toxicol. 12:501-507.
4. Andersen, M.W., Hoel, D.G., and Kaplan, N.L. (1980). A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: Example - Vinyl chloride. Toxicol. Appl. Pharmacol. 55:154-161.
5. Barbin, A. (2000). Etheno-adduct-forming chemicals: From mutagenicity testing to tumor mutation spectra. Mutat. Res. 462:55-69.
6. Barbin, A., Laib, R.J., and Bartsch, H. (1985). Lack of miscoding properties of 7-(2-oxoethyl)guanine, the major vinyl chloride-DNA adduct. Cancer Res. 45:2440-2444.
7. 50) in rodents: A comparison of mono- and bi-functional alkylating agents and vinyl chloride metabolites. Mutat. Res. 215:95-106.
8. Barbin, A., Bresil, H., Croisy, A., Jacquignon, P., Malaveille, C., Montesano, R., and Bartsch, H. (1975). Liver-microsome-mediated formation of alkylating agents from vinyl bromide and vinyl chloride. Biochem. Biophys. Res. Commun. 67(2):596-603.
9. Barbin, A., Froment, O., Boivin, S., Marion, M.J., Belpoggi, F., Maltoni, C., and Montesano, R. (1997). p53 gene mutation pattern in rat liver tumors induced by vinyl chloride. Cancer Res. 57(9):1695-1698.
10. Bartsch, H. (1999). Keynote address: Exocyclic adducts as new risk markers for DNA damage in man. IARC Sci. Publ. 150:1-6.
11. Bartsch, H., and Nair, J. (2002). Potential role of lipid peroxidation derived DNA damage in human colon carcinogenesis: Studies on exocyclic base adducts as stable oxidative stress markers. Cancer Detect. Prev. 26(4):308-312.
12. Bartsch, H., Malaveille, C., Barbin, A., and Planche, G. (1979). Mutagenic and alkylating metabolites of halo-ethylenes, chlorobutadienes, and dichlorobutenes produced by rodent or human liver tissues. Arch. Toxicol. 41:249-277.
13. Bartsch, H., Nair, J., and Owen, R.W. (2002). Exocyclic DNA adducts as oxidative stress markers in colon carcinogenesis: Potential role of lipid peroxidation, dietary fat and antioxidants. Biol. Chem. 283(6):915-921.
14. 4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole. Biochemistry 32(47):12793-801.
15. Block, J.B. (1974). Angiosarcoma of the liver following vinyl chloride exposure. J. Am. Med. Assoc. 229:53-54.
16. Boffetta, P., Matisane, L., Mundt, K.A., and Dell, L.D. (2003). Meta-analysis of studies of occupational exposure to vinyl chloride in ralation to cancer mortality. Scand J. Work Environ. Health 29(3):220-229.
17. Boivin-Angele, S., Lefrancois, L., Froment, O., Spiethoff, A., Bogdanffy, M.S., Wegener, K., Wesch, H., Barbin, A., Bancel, B., Trepo, C., Bartsch, H., Swenberg, J., and Marion, M.J. (2000). Ras gene mutations in vinyl chloride-induced liver tumours are carcinogen-specific but vary with cell type and species. Int. J. Cancer 85(2):223-227.
18. Bolt, H.M. (1978). Pharmacokinetics of vinyl chloride. Gen. Pharmac. 9:91-95.
19. Bolt, H.M. (1988a). Carcinogenicity of ethylene and derivatives: Structural considerations. In: Chemical Carcinogens - Activation Mechanisms, Structural and Electronic Factors, and Reactivity. Bioactive Molecules, Vol. 5., eds. P. Politzer, and F. J. Martin, Jr., pp. 177-187. Amsterdam: Elsevier.
20. Bolt, H. M. (1988b). Roles of etheno-DNA adducts in tumorogenicity of olefins. CRC Crit. Rev. Toxicol. 18(4):299-309.
21. Bolt, H.M., and Filser, J.G. (1983). Quantitative Aspekte der Karzinogenität von Vinylbromid. Verhandlungen der Deutschen Gesellschaft für Arbeitsmedizin, 23. Jahrestagung, Göttingen, pp. 433-437. Stuttgart: Gentner Verlag.
22. Bolt, H.M., and Kappus, H., Buchter, A., and Bolt, W. (1975). Metabolism of vinyl chloride. Lancet. 1(7922):1425.
23. Bolt, H.M., Filser, J.G., Laib, R.J., and Ottenwälder, H. (1980). Binding kinetics of vinyl chloride and vinyl bromide at very low doses. Arch. Toxicol. Suppl. 3:129-142.
24. Bolt, H.M., Filser, J.G., and Buchter, A. (1981). Inhalation pharmacokinetics based on gas uptake studies. III. A pharmacokinetic assessment in man of "peak concentrations" of vinyl chloride. Arch. Toxicol. 48(4):213-228.
25. Bolt, H.M., Laib, R.J., and Filser, J.G. (1982). Reactive metabolites and carcinogenicity of halogenated ethylenes. Biochem. Pharmacol. 31:1-4.
26. Bolt, H.M., Roos, P.H., and Thier, R. (2003). The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: Consequences for occupational and environmental medicine. Int. Arch. Occup. Environ. Health 76(3): 174-185.
27. Buchter, A., Filser, J.G., Peter, H., and Bolt, H.M. (1980). Pharmacokinetics of vinyl chloride in the Rhesus monkey. Toxicol. Lett. 6(1):33-36.
28. Chaudhary, A.K., Nokubo, M., Reddy, G.R., Yeola, S.N., Morrow, J.D., Blair, I.A., and Marnett, L.J. (1994). Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science. 265(5178):1580-1582.
29. Chen, C.W., and Blancato, J.N. (1989). Incorporation of biological information in cancer risk assessment: Example - Vinyl chloride. Cell Biol. Toxicol. 5(4):417-444.
30. 6-ethenoadenine in human placenta) DNA by mass spectrometry. Chem. Res. Toxicol. 12(12):1119-1126.
31. 2,3- ethenoguanine produces G-A transitions in Escherichia coli. Proc. Natl. Acad. Sci. USA. 88(22):9974-9978.
32. Clewell, H.J., Gentry, P.R., Gearhart, J.M., Allen, B.C., and Andersen, M.E. (1995). Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: Examples with vinyl chloride and trichloroethylene. Chemosphere. 31(1):2561-2578.
33. Clewell, H.J., Gentry, P.R., Gearhart, J.M., Allen, B.C., and Andersen, M.E. (2001). Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. Sci. Total Environ. 274(1-3):37-66.
34. Creech, J.S., and Johnson, M.N. (1974). Angiosarcoma of liver in the manufacture of polyvinyl chloride. J. Occup. Med. 16:150-151.
35. De Bont, R., and van Larebeke, N. (2004). Endogenous DNA damage in humans: A review of quantitative data. Mutagenesis. 19(3):169-185.
36. Dixit, R., Riviere, J., Krishnan, K., and Andersen, M.E. (2003). Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment. J. Toxicol. Environ. Health B Crit. Rev. 6(1):1-40.
37. Doerge, D.R., Churchwell, M.I., Fang, J.L., and Beland, F.A. (2000). Quantification of etheno-DNA adducts using liquid chromatography, on-line sample processing, and electrospray tandem mass spectrometry. Chem. Res. Toxicol. 13(12):1259-1264.
38. Doll, R. (1988). Effects of exposure to vinyl chloride. An assessment of the evidence. Scand J. Work Environ. Health. 14:61-78.
39. Drew, R.T., Boorman, G.A., Haseman, J.K., McConnell, E.E., Busey, W.M., and Moore, J.A. (1983). The effect of age and exposure duration on cancer induction by a known carcinogen in rats, mice and hamsters. Toxicol. Appl. Pharmacol. 68:120-130.
40. 4-etheno-2′-deoxycytidine detected by monoclonal antibodies in lung and liver DNA of rats exposed to vinyl chloride. Carcinogenesis. 10(1):209-212.
41. 2,3-ethenoguanine based on electrophore labeling. Carcinogenesis. 11: 1279-1285.
42. 2,3-ethenoguanine in rat tissue DNA. Carcinogenesis. 11:1287-1292.
43. Feron, V.J., Hendriksen, C.F.M., Speek, A.J., Til, H.P., and Spit, B.J. (1981). Lifespan oral toxixity study of vinyl chloride in rats. Food Cosmet. Toxicol. 19:317-333.
44. Filser, J.G., and Bolt, H.M. (1979) Pharmacokinetics of halogenated ethylenes in rats. Arch. Toxicol. 42:123-136.
45. Filser, J.G., and Kreuzer, P.E., Greim, H., and Bolt, H.M. (1994). New scientific arguments for regulation of ethylene oxide residues in skin-care products. Arch. Toxicol. 68(7):401-405.
46. Fox, A.J., and Collier, P.F. (1977). Mortality experience of workers exposure to vinyl chloride monomer in the manufacture of polyvinyl chloride in Great Britain. Br. J. Ind. Med. 34:1-10.
47. 6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepatocarcinogenesis. Carcinogenesis. 25(6):1027-1031.
48. Froment, O., Boivin, S., Barbin, A., Bancel, B., Trepo, C., and Marion, M.J. (1994). Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride. Cancer Res. 54(20):5340-5345.
49. El Ghissassi, F., Barbin, A., and Bartsch, H. (1998). Metabolic activation of vinyl chloride by rat liver microsomes: Low-dose kinetics and involvement of cytochrome P450 2E1. Biochem. Pharmacol. 55:1445-1452.
50. Gehring, P.J., Watanabe, P.G., and Park, C.N. (1978). Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example - vinyl chloride. Toxicol. Appl. Pharmacol. 44(3):581-591.
51. Green, T. (1990). Chloroethylenes: A mechanistic approach to human risk evaluation. Annu. Rev. Pharmacol. Toxicol. 30:73-89.
52. Green, T., and Hathway, D.E. (1978). Interactions of vinyl chloride with rat liver DNA in vivo. Chem. Biol. Interact. 22:211-224.
53. Greim, H., Bonse, G., Radwan, Z., Reichert, D., and Henschler, D. (1975). Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxirane formation. Biochem. Pharmacol. 24(21):2013-2017.
54. Guengerich, F.P. (1992). Roles of the vinyl chloride oxidation products 2-chlorooxirane and 2-chloroacetaldehyde in the in vitro formation of etheno adducts of nucleic acid bases. Chem. Res. Toxicol. 5:2-5.
55. 36Cl labeled vinyl chloride in vivo and in vitro. Biochem. Pharmacol. 28:589-596.
56. Guengerich, F.P., Mason, P.S., Stott, W.T., Fox, T.R., and Watanabe, P.G. (1981). Roles of 2-haloethylene oxides and 2-haloacetaldehydes derived from vinyl bromide and vinyl chloride in irreversible binding to protein and DNA. Cancer Res. 41:4391-4398.
57. Gutacker, H.W., and Lelbach, W.K., eds. (1977). Leberschäden durch Vinylchlorid. Vinylchlorid-Krankheit. Baden-Baden: Verlag Gerhard Witzstrock.
58. Gwinner, L.M., Laib, R.J., Filser, J.G., and Bolt, H.M. (1983). Evidence of chloroethylene oxide being the reactive metabolite of vinyl chloride towards DNA: Comparative studies with 2,2′-dichlorodiethylether. Carcinogenesis 4(11):1483-1436.
59. 4-ethenocytosine are excided by separate human DNA glycosylases. Carcinogenesis 17(1):155-157.
60. 4- ethenocytosine or 8-oxoguanine. Proc. Natl. Acad. Sci. USA 94(24):12869-12874.
61. 4-ethenocytosine and the G/T mismatch. Proc. Natl. Acad. Sci. USA. 95(23):13561-13566.
62. Hata, J., Takamizawa, K., Miyata, N., and Iwahori, K. (2003). Biodegradation of cis-1,2-dichloroethylene and vinyl chloride in anaerobic cultures enriched from landfill leachate sediment under Fe(III)-reducing conditions. Biodegradation. 14(4):275-283.
63. Hollstein, M., Marion, M.J., Lehman, T., Welsh, J., Harris, C.C., Martel-Planche, G., Kusters, I., and Montesano, R. (1994). p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis. 15(1):1-3.
64. Jones, R.B., and Mackrodt, W.C. (1982). Structure-mutagenicity relationships for chlorinated ethylenes: A model based on the stability of the metabolically derived epoxides. Biochem. Pharmacol. 31:3710-3713.
65. Jones, R.B., and Mackrodt, W.C. (1983). Structure - genotoxicity relationship for aliphatic epoxides. Biochem. Pharmacol. 32:2359-2362.
66. Kadlubar, F.F., Anderson, K.E., Häussermann, S., Lang, N.P., Barone, G.W., Thompson, P.A., MacLeod, S.L., Chou, M.W., Mikhailova, M., Plastaras, J., Marnett, L.J., Nair, J., Velic, I., and Bartsch, H. (1998). Comparison of DNA adduct levels associated with oxidative stress in human pancreas. Mutat. Res. 405(2):125-133.
67. Kappus, H., Bolt, H.M., Buchter, A., and Bolt, W. (1976). Liver microsomal uptake of vinyl chloride and transformation to protein alkylating metabolites in vitro. Toxicol. Appl. Pharmacol. 37:461-471.
68. Kielhorn, J., Melber, C., Wahnschaffe, U., Aitio, A., and Mangelsdorff, I. (2000). Vinyl chloride: Still a cause of concern. Environ. Health Perspect. 108(7):579-588.
69. Kirkovsky, L.I., Lermontov, S.A., Zavorin, S.I., Sukhozhenko, I.I., Zavelsky, V.I., Thier, R., and Bolt, H.M. (1998). Hydrolysis of genotoxic methyl-substituted oxiranes: Experimental kinetic and semiempirical studies. Environ. Toxicol. Chem. 17(11):2141-2147.
70. Kjeldsen, P., and Christensen, T.H. (2001). A simple model for the distribution and fate of organic chemicals in a landfill: MOCLA. Waste Manage. Res. 19(3):201-216.
71. 2- Ethenodeoxyguanosine: Properties and formation in chloroacetaldehyde-treated polynucleotides and DNA. Chem. Res. Toxicol. 5:634-638.
72. 6-ethenoadenosine. Toxicology 8:185-195.
73. 4- ethenocytidine in RNA by vinyl chloride metabolites in vitro and in vivo. Arch. Toxicol. 39:235-240.
74. Laib, R.J., and Bolt, H.M. (1980). Trans-membrane alkylation: A new method for studying irreversible binding of reactive metabolites to nucleic acids. Biochem. Pharmacol. 29(3):449-452.
75. Laib, R.J., Gwinner, L.M., and Bolt, H.M. (1981). DNA alkylation by vinyl chloride metabolites: Etheno derivatives or 7-alkylation of guanine? Chem. Biol. Interact. 37(1-2): 219-231.
76. Laib, R., Klein, K.P., and Bolt, H.M. (1985a). The rat liver foci bioassay: I. Age-dependence of induction by vinyl chloride of ATPase-defiocient foci. Carcinogenesis 6(1):65-68.
77. Laib, R.J., Pellio, T., Wünschel, U.M., Zimmermann, N., and Bolt, H.M. (1985b). The rat liver foci bioassay. II. Investigations on the dose-dependent induction of ATPase-deficient foci by vinyl chloride at very low doses. Carcinogenesis 6(1):69-72.
78. Lee, C.C., Bhandari, J.C., Winston, J.M., House, W.B., Dixon, R.L., and Woods, J.S. (1978). Carcinogenicity of vinyl chloride and vinylidene chloride. J. Toxicol. Environ. Health 4:15-30.
79. Lee, F.J., and Harry, D.S. (1974). Angiosarcoma of the liver in a vinyl chloride worker. Lancet 1:1316-1318.
80. Leonard, N.J. (1992). Etheno-bridged nucleotides in structural diagnosis and Carcinogenesis. Chemtracts - Biochem. Mol. Biol. 3:273-297.
81. Leonard, N.J. (1993). Etheno-bridged nucleotides in enzyme reactions and protein binding. Chemtracts - Biochem. Mol. Biol. 4:251-284.
82. Li, Y., Marion, M.J., Asherova, M., Coulibali, D., Smith, S.J., Do, T., Carney, W.P., and Brandt-Rauf, P.W. (1998). Mutant p27ras in vinyl chloride-exposed workers. Biomarkers. 3(6):433-439.
83. Lilly, P.D., Thornton-Manning, J.R., Gargas, M.L., Clewell, H.J., and Andersen, M.E. (1998). Kinetic characterization of CYP2E1 inhibition in vivo and in vitro by the chloroethylenes. Arch. Toxicol. 72(10):609-621.
84. 6-ethenodeoxyadenosine (εA): Formation of εA basepairs and elongation in defined templates. Carcinogenesis. 18(8):1609-1615.
85. Loew, G.H., Kurkjian, E., and Rebagliati, M. (1983). Metabolism and relative carcinogenic potency of chloroethylenes: A quantum chemical structure-activity study. Chem. Biol. Interact. 43:33-66.
86. Malaveille, C., Bartsch, H., Barbin, A., Camus, A.M., Montesano, R., Croisy, A., and Jacquignon, P. (1975). Mutagenicity of vinyl chloride, chloroethylene oxide, chloroacetaldehyde and chloroethanol. Biochem. Biophys. Res. Commun. 63(2):363-70.
87. Maltoni, C. (1977). Recent findings on the carcinogenicity of chlorinated olefins. Environ. Health Perspect. 21:1-5.
88. Maltoni, C., and Lefemine, G. (1975). Carcinogenicity bioassays of vinyl chloride: current results. Ann. NY Acad. Sci. 246:195-218.
89. Maltoni, C., Lefemine, C., Chieco, P., and Carretti, D. (1974). Vinyl chloride Carcinogenesis. Current results and perspectives. Med. Lav. 65(11-12):421-444.
90. Maltoni, C., Lefemine, G., Ciliberti, A., Cotti, G., and Carretti, D. (1981). Carcinogenicity bioassay of vinyl chloride monomer: A model of risk assessment on an experimental basis. Environ. Health Perspect. 41:3-29.
91. Maltoni, C., Lefemine, G., Ciliberti, A., Cotti, G., and Carretti, D. (1984). Experimental research on vinyl chloride carcinogenesis. Archives of Research on Industrial Carcinogenesis, Vol. II. Princeton, NJ: Princeton Scientific.
92. Marion, M.J., Froment, O., and Trepo, C. (1991). Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure. Mol. Carcinogen. 4(6):450-454.
93. Maronpot, R.R., Fox, T., Malarkey, D.E., and Goldsworthy, T.L. (1995). Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 101(3):125-156.
94. Marsteller, H.J., Lelbach, W.K., Müller, R., and Gedigk, P. (1975). Unusual splenomegalic liver disease as evidenced by peritoneoscopy and guided liver biopsy among polyvinyl chloride production workers. Ann. NY Acad. Sci. 246:95-135.
95. Mersiowsky, I., Weller, M., and Ejlertsson, J. (2001). Fate of plasticised PVC products under landfill conditions: A laboratory-scale landfill simulation reactor study. Water Res. 35(13):3063-3070.
96. 2,3-ethenoguanine in human and rat liver DNA using high resolution mass spectrometry. Proc. Am. Assoc. Cancer Res. 36:142 (abst).
97. 2-ethenoguanine with an immunoaffinity/gas chromatography/high- resolution mass spectrometry assay. Chem. Res. Toxicol. 14:327-334.
98. 2,3-ethenoguanine in rat brain and liver after exposure to vinyl chloride. Cancer Res. 62(18):5183-5188.
99. Morinello, E.J., Ham, A.J., Ranasinghe, A., Nakamura, J., Upton, P.B., and Swenberg, J.A. (2002b). Molecular dosimetry and repair of N(2),3-ethenoguanine in rats exposed to vinyl chloride. Cancer Res. 62(18):5189-5195.
100. Moriya, M., Zhang, W., Johnson, F., and Grollman, A.P. (1994). Mutagenic potency of exocyclic DNA adducts: Marked differences between Escherichia coli and simian kidney cells. Proc. Natl. Acad. Sci. USA. 91(25):11899-11903.
101. 2,3-ethenoguanine studied in an Escherichia coli DNA-dependent RNA polymerase in vitro system and possible role of this adduct in vinyl chloride-induced mutagenesis. Mutagenesis. 6(5):385-390.
102. Müller, K.T., Buchter, A., Gross, R., and Bolt W. (1976). Ergebnisse einer Studie an 17 Fällen von Langzeitexposition gegenüber Vinylchlorid. Med. Welt. (NF). 27:21-24.
103. Mundt, K.A., Dell, L.D., Austin, R.P., Luippold, R.S., Noess, R., and Bigelow, C. (2000). Historical cohort study of 10,109 men in the North American vinyl chloride industry, 1942-1972: Update of cancer mortality to 31 December 1995. Occup. Environ. Med. 57:778-781.
104. 32P-postlabelling. Carcinogenesis. 16(3):613-617.
105. Osterman-Golkar, S., Hultmark, D., Segerback, D., Calleman, C. J., Göthe, R., Ehrenberg, L., and Wachtmeister, C.A. (1977). Alkylation of DNA and proteins in mice exposed to vinyl chloride. Biochem. Biophys. Res. Commun. 76(2):259-266.
106. Ottenwälder, H., and Bolt, H.M. (1980). Metabolic activation of vinyl chloride and vinyl bromide by isolated hepatocytes and hepatic sinusoidal cells. J. Environ. Pathol. Toxicol. 4:411-417.
107. 6- Ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. Biochemistry. 35(35):11487-11492.
108. Pessayre, D., Wandscheer, J.C., Descatoire, V. Dolder, A., Degott, C., and Benhamou, J.P. (1980). Cumulative effects of repeated doses of compounds transformed into reactive metabolites. Biochem. Pharmacol. 29(7):1041-1047.
109. Popper, H., and Gheorgiu, T. (1977). Einleitung zum Problem der Vinylchlorid-Krankheit. In: Leberschäden durch Vinylchlorid, eds. H. W., Gutacker, and W. K., Lelbach, pp. 11-16. Baden-Baden: Verlag Gerhard Witzstrock.
110. Popper, H., Thomas, L.B., and Schaffner, F. (1977). Interaction between sinusoidal cells and hepatocytes in human and experimental angiosarcoma induced by environmental factors. In: Kupffer Cells and Other Sinusoidal Cells, eds. E., Wisse and D. L., Knook, pp. 173-181. Amsterdam: Elsevier/North Holland.
111. Purchase, I.F., Stafford, J., and Paddle, G.M. (1987). Vinyl chloride: An assessment of the risk of occupational exposure. Food Chem. Toxicol. 25(2):187-202.
112. Reitz, R.H., Gargas, M.L., Andersen, M.E., Provan, W.M., and Green, T.L. (1996). Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic model. Toxicol. Appl. Pharmacol. 137(2):253-267.
113. Schaffner, F. (1978). Effect of long-term vinyl chloride exposure in mouse liver structure. In: Primary Liver Tumors, eds. H., Remmer, H. M., Bolt, P., Bannasch, and H., Popper, pp. 188-199. Lancaster, UK: MTP Press.
114. Saito, T., Barbin, A., Omori, Y., and Yamasaki, H. (1997). Connexin 37 mutations in rat hepatic angiosarcomas induced by vinyl chloride. Cancer Res. 57(3):375-377.
115. 4-Ethenocytosine, a highly mutagenic adduct, is a primary substrate for Escherichia coli double-stranded uracil-DNA glycosylase and human mismatch-specific thymine-DNA glycosylase. Proc. Natl. Acad. Sci. USA. 95(15):8508-8513.
116. Schumann, A.M., Watanabe, P.G., Reitz, R.H., and Gehring, P.J. (1982). The importance of pharmacokinetic and macromolecular events as they relate to mechanisms of tumourigenicity and risk assessment. In: Toxicology of the Liver, eds. G. Plaa and W. R. Hewitt, Target Organ Toxicology Series, pp. 311-331. Raven Press. New York: pp. 311-331.
117. SCOEL. (in press). Recommendation from Scientific Committee on Occupational Exposure Limits: Risk assessment for vinyl chloride. In: Occupational Exposure Limits. Recommendations of the Scientific Committee for Occupational Exposure Limits to Chemical Agents. European Commission, Employment and Social Affairs, Luxemburg: Office for Official Publications of the European Communities.
118. 4-etheno-2′-deoxycytidine in reactions catalyzed by mammalian DNA polymerases. Biochemistry. 35(47):14992-14998.
119. Simha, D., Palejwala, V.A., and Humayun, M.Z. (1991). Mechanisms of mutagenesis by exocyclic DNA adducts. Construction and in vitro template characteristics of an oligonucleotide bearing a single site-specific ethenocytosine. Biochemistry. 30(36):8727-8735.
120. Simonato, L., L'Abbe, K.A., Andersen, A., Belli, S., Comba, P., Engholm, G., Ferro, G., Hagmar, L., Langard, S., and Lundberg, I. (1991). A collaborative study of cancer incidence and mortality among vinyl chloride workers. Scand. J. Work Environ. Health 17:159-169.
121. Singer, B., and Essigmann, J.M. (1991). Site-specific mutagenesis: Retrospective and prospective. Carcinogenesis. 12(6):949-955.
122. 2,3-ethenoguanosine, is a highly efficient mutagen in transcription. Carcinogenesis. 8(5):745-747.
123. 2,3-etheno-deoxyguanosine, using a site-directed kinetic assay. Carcinogenesis. 12:745-747.
124. Smith, S.J., Li, Y., Whitley, R., Marion, M.J., Partilo, S., Carney, W.P., and Brandt-Rauf, P.W. (1998). Molecular epidemiology of p53 protein mutations in workers exposed to vinyl chloride. Am. J. Epidemiol. 147(3):302-308.
125. Sokal, J.A., Baranski, B., Majka, J., Rolecki, R., Stetkiewicz, J., Ivanova-Chemishanska, L., Vergieva, T., Antonov, G., Mirkova, E., and Kolakovski, A. (1980). Experimental studies on the chronic toxic effects of vinyl chloride in rats. J Hyg. Epidemiol. Microbiol. Immunol. 24:285-294.
126. Stanley, L.A. (1995). Molecular aspects of chemical Carcinogenesis: The roles of oncogenes and tumour suppressor genes. Toxicology 96(3):173-194.
127. Streffer, C., Bolt, H.M., Føllesdal, D., Hall, P., Hengstler, J.G., Jakob, P., Oughton, D., Priess, K., Rehbinder, E., and Swaton, E. (2004). Low Dose Exposures in the Evironment. Dose-Effect Relations and Risk Evaluation. Berlin: Springer.
128. Swenberg, J.A., Fedtke, N., Ciroussel, F., Barbin, A., and Bartsch, H. (1992). Etheno adducts formed in DNA of vinyl chloride-exposed rats are highly persistent in liver. Carcinogenesis 13(4):727-729.
129. Swenberg, J.A., Bogdanffy, M.S., Ham, A., Holt, S., Kim, A., Morinello, E.J., Ranasinghe, A., Scheller, N., and Upton, P.B. (1999). Formation and repair of DNA adducts in vinyl chloride- and vinyl fuoride-induced carciniogenesis. IARC Sci. Publ. 150:29-43.
130. Swenberg, J.A., Ham, A., Koc, H., Morinello, E., Ranasinghe, A., Tretyakova, N., Upton, P.B., and Wu, K.Y. (2000). DNA adducts: Effects of low exposure to ethylene oxide, vinyl chloride and butadiene. Mutat. Res. 464:77-86.
131. Thier, R., and Bolt, H.M. (2000). Carcinogenicity and genotoxicity of ethylene oxide: New aspects and recent advances. Crit. Rev. Toxicol. 30(5):595-608.
132. Til, H.P., Immel, H.P., and Feron, V.J. (1983). Lifespan Oral Carcinogenicity Study of Vinyl Chloride in Rats. Division for Nutrition and Food Research TNO. TNO Report V 83.285/291099. Zeist/NL: TNO.
133. Til, H.P., Feron, V.J., and Immel, H.R. (1991). Lifetime (149-week) oral carcinogenicity study of vinyl chloride in rats. Food Chem. Toxicol. 29:713-718.
134. U.S. Environmental Protection Agency. (2000). Vinyl chloride. IRIS File Online, U.S. Environmental Protection Agency, Washington, DC, available on http://www.epa.gov/iris/subst/1001.htm.
135. Ward, E., Boffetta, P., Andersen, A., Colin, D., Comba, P., Dedens, J. A., De Santis, M., Engholm ,G., Hagmar, L., Langard, S., Lundberg, I., McElvenny, D., Pirastu, R., Sali, D., and Simonato, L. (2001). Update of the follow-up of mortality and cancer incidence among European workers employed in the vinyl chloride industry. Epidemiology 12:710-718.
136. Watababe, P.G., and Gehring, P.J. (1976). Dose-dependent fate of vinyl chloride and its possible relationship to oncogenicity in rats. Environ. Health Perspect. 17:145-152.
137. 14C]vinyl chloride following inhalation exposure in rats. Toxicol. Appl. Pharmacol. 37(1):49-59.
138. 14C]vinyl chloride after single oral administration in rats. Toxicol. Appl. Pharmacol. 36(2):339-352.
139. Watanabe, P.G., Zempel, J.A., and Gehring, P.J. (1978). Comparison of the fate of vinyl chloride following single and repeated exposure in rats. Toxicol. Appl. Pharmacol. 44(2):391-399.
140. Weihrauch, M., Benicke, M., Lehnen, G., Wittekind, C., Wrbitzky, R., and Tannapfel, A. (2001). Frequent k-ras-2 mutations and p16(INK4A) methylation in hepatocellular carcinomas in workers exposed to vinyl chloride. Br. J. Cancer 84(7):982-989.
141. Weihrauch, M., Bader, M., Lehnen, G., Koch, B., Wittekind, C., Wrbitzky, R., and Tannapfel, A. (2002a). Mutation analysis of K-ras-2 in liver angiosarcoma and adjacent nonneoplastic liver tissue from patients occupationally exposed to vinyl chloride. Environ. Mol. Mutagen. 40(1):36-40.
142. Weihrauch, M., Markwarth, A., Lehnert, G., Wittekind, C., Wrbitzky, R., and Tannapfel, A. (2002b). Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver. Hum. Pathol. 33(9):884-892.
143. Whysner, J., Conaway, C.C., Verna, L., and Williams, G.M. (1996). Vinyl chloride mechanistic data and risk assessment: DNA reactivity and cross-species quantitative risk extrapolation. Pharmacol. Ther. 71(1-2):7-28.
144. Wiseman, R.W., Stowers, S.J., Miller, E.C., Anderson, M.W., and Miller, J.A. (1986). Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. Proc. Natl Acad. Sci. USA. 83(16):5825-5829.
145. Wisniewska-Knypl, J.M., Klimczak, J., and Kolakowski, J. (1980). Monooxygenase activity and ultrastructural changes of liver in the course of chronic exposure of rats to vinyl chloride. Int. Arch. Occup. Environ. Health. 46:241-249.
146. Wong, R.H., Wang, J.D., Hsieh, L.L., and Cheng, T.J. (2003). XRCC1, CYP2E1 and ALDH2 genetic polymorphisms and sister chromatid exchange frequency amongst vinyl chloride monomer-exposed polyvinyl chloride workers. Arch. Toxicol. 77(8):433-440.
147. World Health Organization. (1987). Air Quality Guidelines for Europe. WHO Regional Publications, European Series No. 23. Copenhagen: World Health Organization (WHO) Regional Office.
148. World Health Organization. (1999). Vinyl Chloride. Environmental Health Criteria 215. Geneva: World Health Organization, International Programme on Chemical Safety.
149. World Health Organization. (2000). Air Quality Guidelines for Europe, 2nd ed. WHO Regional Publications, European Series, No. 91. Copenhagen: World Health Organization (WHO) Regional Office.
150. 6-ethenodeoxyadenosine, a promutagenic DNA adduct, in liver of rats exposed to vinyl chloride or an iron overload. Carcinogenesis 21(4):777-781.
151. 2,3-ethenoguanine using liquid chromatography/electrospray ionization mass spectrometry. J. Mass Spectrom. 31(11):1271-1276.